Missouri abortion clinic to stay open for now after court order

ST. LOUIS (Reuters) – Missouri’s only abortion clinic will stay open at least a few more days after a judge on Friday granted a request by Planned Parenthood for a temporary restraining order, allowing the facility to keep operating until a hearing on Tuesday.

Pro-Choice and Pro-Life protesters stand outside of Planned Parenthood as a deadline looms to renew the license of Missouri’s sole remaining Planned Parenthood clinic in St. Louis, Missouri, U.S. May 31, 2019. REUTERS/Lawrence Bryant

Missouri abortion clinic to stay open for now after court order

A Missouri State Flag waves outside the Reproductive Health Services of Planned Parenthood St. Louis Region, Missouri’s sole abortion clinic, in St. Louis, Missouri, U.S. May 28, 2019. REUTERS/Lawrence Bryant

NEW YORK (Reuters) – A Missouri court on Friday granted Planned Parenthood’s request for a temporary restraining order, letting the state’s only abortion clinic stay open until June 4 when another hearing will be held, according to a court order.

Planned Parenthood sued Missouri this week after state health officials said the license for Reproductive Health Services of Planned Parenthood in St. Louis was in jeopardy, meaning the clinic could have closed at midnight unless the judge granted the request for a temporary restraining order.

It’s Never Too Late for New Brain Cells

News Picture: It's Never Too Late for New Brain Cells

Latest Alzheimer’s News

WEDNESDAY, May 29, 2019 (HealthDay News) — New research delivers fresh hope for everyone who struggles with a fading memory: Neurons continue to form well into old age, even in people with mental impairments or Alzheimer’s disease.

“We found that there was active neurogenesis [new neurons forming] in the hippocampus of older adults well into their 90s,” said study author Orly Lazarov, a professor of anatomy and cell biology at the University of Illinois at Chicago.

“The interesting thing is that we also saw some new neurons in the brains of people with Alzheimer’s disease and cognitive [thinking] impairment,” she added in a university news release.

Don’t let tobacco take your breath away

Hooked on tobacco? Make today, World “No Tobacco” Day, the perfect time to kick butts—cigarette butts, that is. This year’s theme is “tobacco and lung health.” According to the World Health Organization, tobacco smoking is the top cause for lung cancer, responsible for over two thirds of lung cancer deaths globally. Second-hand smoke exposure also increases risk of lung cancer.

When you stop smoking, you can   reduce your risk of lung cancer. After 10 years of not smoking, your risk of lung cancer falls to about half that of a smoker.

Immune system discovery may lead to new models for diagnosing inflammatory diseases

A unique discovery about the nature of neutrophils — the most numerous white blood cells in the body — may lead to new models for diagnosing and tracking inflammatory diseases such as cancer and osteoarthritis.

The “first responders” of the body, neutrophils are a class of leukocyte immune cell in the “innate” immune system, which deals with acute infections. Billions of neutrophils are born in the bone’s marrow each day to protect the body and attack microbial invaders.

The general consensus in the past was that there is one kind of neutrophil in circulation in healthy people.”

Newly identified internal regulator helps control body’s response to fight infection

Scientists have identified a new internal regulator which helps control the body’s response to fight infection.

The discovery could be a target for new drugs to tackle autoimmune diseases, such as lupus and scleroderma, where healthy tissues are attacked by the body’s own immune system.

We want to put a brake on the body’s own immune system to stop it turning on itself. Our discovery has the potential to help us find a new drug to target this regulator, to suppress the immune system and stop the body destroying its own cells, even when there is no infection present. We’re a long way off being able to find a new effective treatment for autoimmune disease, but we’re excited because this discovery could open the door to a new class of drugs.”

Congo’s Ebola epidemic inflicts heavy toll on children

BUTEMBO, Democratic Republic of Congo (Reuters) – Eight-year-old Kennedy Muhindo was running a high fever and racked by stomach pain and diarrhea.

Health workers told him he had Ebola but his first thought was for his sister who had been battling the virus.

“How is my big sister doing?” he asked health workers again and again at an Ebola treatment center on the outskirts of Butembo, a major trading hub set amid volcanic hills in eastern Democratic Republic of Congo.

Staff said they didn’t have the heart to tell him that 9-year-old Lareine had died.

Children under five dying at higher rate in Congo Ebola epidemic: WHO

GENEVA (Reuters) – Children under five infected with Ebola in eastern Democratic Republic of Congo are dying at a higher rate than other patients as their parents shun special treatment centers, the World Health Organization (WHO) said on Thursday.

FILE PHOTO: Rachel Kahindo, an Ebola survivor working as a caregiver to babies who are confirmed Ebola cases, holds an infant outside the red zone at the Ebola treatment centre in Butembo, Democratic Republic of Congo, March 25, 2019. REUTERS/Baz Ratner/File Photo

High LDL Cholesterol Tied to Early-Onset Alzheimer’s

News Picture: High LDL Cholesterol Tied to Early-Onset Alzheimer'sBy Steven Reinberg
HealthDay Reporter

Latest Alzheimer’s News

WEDNESDAY, May 29, 2019 (HealthDay News) — Here’s another reason to keep your cholesterol under control: New research suggests that LDL, or “bad,” cholesterol may play a role in the development of early-onset Alzheimer’s.

A rare form of the disease that occurs before the age of 65, early-onset Alzheimer’s has previously been linked to a gene mutation involved in how the body processes fats and cholesterol. But that mutation only accounts for a small percentage of cases, the scientists noted.

Scientists move a step closer to developing targeted therapies for inflammatory diseases

Pioneering research by scientists at the Universities of Oxford and Birmingham published today [May 29th] in Nature brings us a step closer to developing targeted therapies for inflammatory diseases.

The research team shows, for the first time, that different types of fibroblasts – the most common cells of connective tissue in animals – are organized in different layers in the joint and are responsible for two very different forms of arthritis; osteoarthritis and rheumatoid arthritis.

Targeted therapies could alter the behavior of fibroblasts to reduce inflammation and tissue destruction in these two diseases without the need for long-term immunosuppression or joint replacements, say the scientists.